Market Research Report
Epiomic Epidemiology Series: Hypertension Forecast in 19 Major Markets 2018-2028
|Published by||Black Swan Analysis||Product code||403740|
|Published||Content info||70 Pages
Delivery time: 1-2 business days
|Epiomic Epidemiology Series: Hypertension Forecast in 19 Major Markets 2018-2028|
|Published: August 1, 2018||Content info: 70 Pages||
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Hypertension in 19 Major Markets
Hypertension (high blood pressure) is a common condition in which the force of the blood against the artery walls is high enough that it may eventually cause serious health problems. These health problems include heart attack, stroke, chronic kidney disease and heart failure.
This report provides the current prevalent population for Hypertension across 19 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Hypertension have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.
Chronic heart failure
Chronic kidney disease
Ischaemic heart disease
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information from patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Ability to quantify patient populations in global Hypertension market to target the development of future products, pricing strategies and launch plans.
Further insight into the prevalence of the subdivided types of Hypertension and identification of patient segments with high potential.
Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
Better understanding on the impact of specific co-morbid conditions on the prevalent population of Hypertension patients.
Identification of Hypertension patient sub-populations that require treatment.
Better understanding of the specific markets that have the largest number of Hypertension patients.